Combining Oxytetracycline, a broad-spectrum antibiotic and Flunixin, a nonsteroidal analgesic with anti-inflammatory, anti-endotoxic and anti-pyretic properties.

Hexasol LA is specifically formulated to provide initial antiinflammatory activity for 24-36 hours and sustained antibacterial activity for 5-6 days following a single administration.

Hexasol LA is indicated primarily for the treatment of bovine respiratory disease associated with Mannheimia haemolytica, where an anti-inflammatory and anti-pyretic effect is required.

In addition a wide range of organisms including Pasteurella spp, Arcanobacterium pyogenes, Staphylococcus aureus and certain mycoplasmas are known to be sensitive in vitro to oxytetracycline.

Hexasol LA may, therefore, be of use in the treatment of disease in cattle caused by such organisms where both antiinflammatory and anti-pyretic effect is required